Stocktoria
Oric Pharmaceuticals, Inc. ORIC
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-04-24
Oric Pharmaceuticals, Inc. statistics & valuation
Market cap$986.5M
P / B2.6×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -31.7% | -46.6% | -40.0% | -36.1% | -26.4% |
| Return on equity | -33.7% | -52.6% | -44.9% | -40.1% | -28.8% |
| Debt / equity | — | — | — | — | 0.04× |
| Current ratio | 14.13 | 10.56 | 10.39 | 13.68 | 15.87 |
Source: SEC EDGAR filings · CIK 0001796280 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.